Liquid fibrin sealant (OMRIX Biopharmaceuticals)

N/A

Report date: 2022/03/17 15:00:59

Base Information

Drug NameLiquid fibrin sealant (OMRIX Biopharmaceuticals)
Drug Alias NameQuixilEvicel
ClassificationBiologics > Blood components
Mechanisms of ActionThrombin replacementsFibrinogen replacements
TargetsProthrombin
Therapy Area/IndicationsBlood Loss, SurgicalHemorrhageCerebrospinal Fluid Leak
Global Approved IndicationsBlood Loss, SurgicalHemorrhage
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2003/03/21
Country/TerritoryBelgiumCanadaUnited States +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOmrix Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOmrix Biopharmaceuticals NvEthicon Inc
Active IndicationsHemorrhage
Inactive IndicationsBlood Loss, SurgicalCerebrospinal Fluid Leak

Other Information

ATC CodeB02BB01
Related LinksDrugBank